Tuesday, June 23, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 982 of 1,261

  1. US 7829081

    Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

    HALOZYME, INC. · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted

  2. US 7829074

    Hydroxypatite-targeting poly(ethylene glycol) and related polymers

    Nektar Therapeutics · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted

  3. US 7829102

    Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted

  4. US 7829304

    Compounds and related methods for mutant p53 reactivation

    Northwestern University · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted

  5. US 7829503

    Methods of identifying compounds that target tRNA splicing endonuclease and uses of said compounds as anti-fungal agents

    PTC THERAPEUTICS, INC. · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted

  6. US 7829279

    Compositions and methods for diagnosis and treatment of epilepsy

    The Regents of the University of California · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted

  7. US 7829561

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted

  8. US 7829583

    Biphenyl derivatives

    Theravance, Inc. · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted

  9. US 2010280048

    Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase

    ASTRAZENECA R & D [SE] · Granted Nov 4, 2010 · Expires Oct 30, 2030

    granted

  10. US 2010280081

    ANTI-INFLAMMATORY AGENTS AS VIROSTATIC COMPOUNDS

    4SC AG [DE] · Granted Nov 4, 2010 · Expires Oct 30, 2030

    granted

  11. US 7825150

    Compositions and methods for treating immunological and inflammatory diseases and disorders

    LEXICON PHARMACEUTICALS, INC. · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  12. US 7825231

    Method of amidated peptide biosynthesis and delivery in vivo: endomorphin-2 for pain therapy

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  13. US 7825159

    Mixtures of aromatic esters for marking or tagging organic products, marker compositions comprising the same and manufacturing methods thereof

    UNITED COLOR MANUFACTURING, INC. · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  14. US 7825216

    Phenylanine derivatives

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  15. US 7825269

    Ligands for nematode nuclear receptors and uses thereof

    The Board of Regents of the University of Texas System · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  16. US 7825265

    Compounds with activity at estrogen receptors

    ACADIA Pharmaceuticals Inc. · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  17. US 7825278

    Substituted enaminones, their derivatives and uses thereof

    The Regents of the University of California · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  18. US 7825127

    Method for treating cancer

    Takeda Pharmaceutical Company Limited · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  19. US 7825142

    Heterocyclic compounds, compositions comprising them and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  20. US 7825242

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  21. US 7825096

    O6-alkylguanine-DNA alkyltransferase inactivators and beta-glucuronidase cleavable prodrugs

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  22. US 7825126

    Purine derivatives as A3 and A1 adenosine receptor agonists

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  23. US 7825116

    N2, N4-bis-aryl-5-fluoro-2,4-pyrimidinediamines

    Rigel Pharmaceuticals, Inc. · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  24. US 7825136

    Potentiators of antibacterial activity

    Vertex Pharmaceuticals Incorporated · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.